CS logo
small CS logo
Moffitt Cancer Center - Magnolia Campus

Tampa, Florida, United States
Cancer treatment center in Tampa, Florida
12902 USF Magnolia Drive, Tampa, FL 33612

About Moffitt Cancer Center - Magnolia Campus


"At Moffitt Cancer Center, we are working tirelessly in the areas of patient care, research and education to advance one step further in fighting cancer."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Moffitt Cancer Center - Magnolia Campus


During the past decade, Moffitt Cancer Center - Magnolia Campus conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Moffitt Cancer Center - Magnolia Campus" #1 collaborator was "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "Norfolk and Norwich University Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "Zuyderland Medical Centre" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Moffitt Cancer Center - Magnolia Campus


According to Clinical.Site data, the most researched conditions in "Moffitt Cancer Center - Magnolia Campus" are "Cutaneous Melanoma, Stage II" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Moffitt Cancer Center - Magnolia Campus" in a lesser frequency.

Clinical Trials Intervention Types at Moffitt Cancer Center - Magnolia Campus


Most popular intervention types in "Moffitt Cancer Center - Magnolia Campus" are "Biological" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Wide Local Excision = 1cm Margin" (1 trials), "Wide Local Excision = 2cm Margin" (1 trials), "docetaxel" (1 trials), "pembrolizumab" (1 trials) and "quaratusugene ozeplasmid" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Moffitt Cancer Center - Magnolia Campus


The vast majority of trials in "Moffitt Cancer Center - Magnolia Campus" are 2 trials for "All" genders.

Clinical Trials Status at Moffitt Cancer Center - Magnolia Campus


Currently, there are NaN active trials in "Moffitt Cancer Center - Magnolia Campus". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Moffitt Cancer Center - Magnolia Campus, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Moffitt Cancer Center - Magnolia Campus, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".